These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 446409)
21. Elevated levels of calcitonin mRNA: a marker for the spontaneous development of medullary thyroid carcinoma in rats. Delehaye MC; Cohen R; Segond N; Pidoux E; Treilhou-Lahille F; Milhaud G; Moukhtar MS Biochem Biophys Res Commun; 1989 Mar; 159(2):528-35. PubMed ID: 2930528 [TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma. Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348 [TBL] [Abstract][Full Text] [Related]
23. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements. Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170 [TBL] [Abstract][Full Text] [Related]
24. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611 [TBL] [Abstract][Full Text] [Related]
25. Clonal strains of rat medullary thyroid carcinoma cells that produce neurotensin and calcitonin. Functional and morphologic studies. Zeytinoglu FN; Gagel RF; DeLellis RA; Wolfe HJ; Tashjian AH; Hammer RA; Leeman SE Lab Invest; 1983 Oct; 49(4):453-9. PubMed ID: 6353060 [TBL] [Abstract][Full Text] [Related]
26. Role of cytosolic free calcium concentration in the secretion of calcitonin gene-related peptide and calcitonin from medullary thyroid carcinoma cells. Haller-Brem S; Muff R; Petermann JB; Born W; Roos BA; Fischer JA Endocrinology; 1987 Oct; 121(4):1272-7. PubMed ID: 3498624 [TBL] [Abstract][Full Text] [Related]
27. Calcitonin secretion, C cell differentiation and proliferation during the spontaneous development of murine medullary thyroid carcinoma. Lausson S; Volle GE; Bourges M; Pidoux E; Borrel C; Milhaud G; Moukhtar MS; Jullienne A; Treilhou-Lahille F Virchows Arch; 1995; 426(6):611-7. PubMed ID: 7655743 [TBL] [Abstract][Full Text] [Related]
29. Transplantable calcitonin-secreting medullary carcinomas of the thyroid in the WAG-Rij rat. Boorman GA; Heersche JN; Hollander CF J Natl Cancer Inst; 1974 Oct; 53(4):1011-5. PubMed ID: 4427386 [No Abstract] [Full Text] [Related]
30. Immunoassay of calcitonin in rat medullary thyroid carcinoma. Deftos LJ; Boorman GA; Roos BA Horm Metab Res; 1976 Jan; 8(1):83-4. PubMed ID: 1248795 [No Abstract] [Full Text] [Related]
31. A monoclonal antibody against rat calcitonin inhibits the growth of a rat medullary thyroid carcinoma cell line in vitro. Zhang R; DeGroot LJ Endocrinology; 1997 Apr; 138(4):1697-703. PubMed ID: 9075733 [TBL] [Abstract][Full Text] [Related]
32. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Trimboli P; Rossi F; Baldelli R; Laurenti O; Nigri G; Ventura C; Appetecchia M; Attanasio D; Romanelli F; Guidobaldi L; Guarino M; Crescenzi A; Valabrega S Diagn Cytopathol; 2012 May; 40(5):394-8. PubMed ID: 21563324 [TBL] [Abstract][Full Text] [Related]
33. Ghrelin in human medullary thyroid carcinomas. Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236 [TBL] [Abstract][Full Text] [Related]
34. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. Lippman SM; Mendelsohn G; Trump DL; Wells SA; Baylin SB J Clin Endocrinol Metab; 1982 Feb; 54(2):233-40. PubMed ID: 6798062 [TBL] [Abstract][Full Text] [Related]
36. Altered expression of the calcitonin gene associated with RNA polymorphism. Rosenfeld MG; Amara SG; Roos BA; Ong ES; Evans RM Nature; 1981 Mar; 290(5801):63-5. PubMed ID: 7207587 [TBL] [Abstract][Full Text] [Related]
37. Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase. Quidville V; Segond N; Pidoux E; Cohen R; Jullienne A; Lausson S Endocrinology; 2004 May; 145(5):2561-71. PubMed ID: 14736730 [TBL] [Abstract][Full Text] [Related]
38. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma. Raue F; Blind E; Grauer A Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876 [TBL] [Abstract][Full Text] [Related]
39. C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis. DeLellis RA; Nunnemacher G; Bitman WR; Gagel RF; Tashjian AH; Blount M; Wolfe HJ Lab Invest; 1979 Feb; 40(2):140-54. PubMed ID: 431034 [TBL] [Abstract][Full Text] [Related]
40. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma. Takami H; Ito K Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]